Recalls for FDAs

Revatio (sildenafil): Drug Safety Communication - FDA clarifies Warning About Pediatric Use for Pulmonary Arterial Hypertension
03/31/2014 Medical Recall

Health care professionals must consider whether the benefits of treatment with the drug are likely to outweigh its potential risks for each patient.

  • Company:
    FDAs